BILLS-117hr4369rfs.pdf

one year the 21st Century 2021 a fiscal year 1ST SESSION H. R. 4369 annually annual later than 2 years 6 day later than 90 days 4369 the period of fiscal years 2022 through 2026 21st 5 1965 October 19 OCTOBER 20, 2021

the ‘‘National Centers of

PO 00000 Frm 00007 PO 00000 Frm 00010 PO 00000 Frm 00002 PO 00000 Frm 00001 PO 00000 Frm 00012

the United States of America THE UNITED STATES

DSK79L0C42PROD Congress Centers of Excellence a National Center of Excellence National Centers of Excellence Excellence National FDA Drug Administration House of Representa- Continuous Pharmaceutical Manufacturing DESIGNATION.—A Sec the Food and Drug Adminis- National Center of Excellence Food fed the Commissioner of Food and Drugs National Centers National Cen- SENATE the Food and Drug Ad- 21 Labor the Food and Drug Administra- the National Center of Excel- Centers the Committee on Health, Education Continuous Food and Drug Administration the Food and Drug U.S.C. the House of Representatives Continuous Pharmaceutical Manufac- neous Health and Human Services Continuous Pharmaceutical National Centers of Excellence the National Centers of Excellence Center for Excellence the Department of Health the Food and Drug Administration CEUTICAL MANUFACTURING APPROPRIATIONS

kjohnson CHERYL L. JOHNSON

advanced continuous pharmaceutical manufacturing continuous pharmaceutical ceutical pharma ceutical pharma manufacturing advanced centers excellence excellence manufacturers institutions higher consortium bills rfs